Name | LILLI FARMA, OOO |
|---|
INN | 7702219484 |
|---|
KPP | 770301001 |
|---|
OGRN | 1037739728333 |
|---|
OKPO | 18467282 |
|---|
Address | 123112, G.moskva, nab. Presnenskaya, d. D.10 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 46.46 | Core activity | Wholesale of pharmaceutical goods | | 21.20 | Additional activity | Manufacturers of drugs and pharmaceuticals and medical products | | 21.20.1 | Additional activity | Production of drugs | | All types of activities | | 21.20.2 | Additional activity | Production of materials used in medical applications | | 46.18.1 | Additional activity | Agents specialized in the wholesale trade of pharmaceutical products, products used for medical purposes, perfume and cosmetics, including soap and detergents | | 47.73 | Additional activity | Retailing drugs in specialized stores (pharmacies) | | 52.10 | Additional activity | Activity Warehousing and storage | | 52.29 | Additional activity | Service activities incidental to land transportation | | 71.2 | Additional activity | Technical testing, analysis and certification | | 71.20.9 | Additional activity | Activities for technical control, testing and other analysis | | 72.19 | Additional activity | Research and experimental development on natural sciences and engineering Other | | 73.20.1 | Additional activity | Market and opinion research | | 82.99 | Additional activity | Other business support services to businesses and individuals not otherwise specified |
Registration date | 19.02.2003 |
|---|
Registering department | Mezhrayonnaya inspektsiya Ministerstva Rossiyskoy Federatsii po nalogam i sboram N39 po g. Moskve |
|---|
|
LILLI FARMA, OOO (Moscow; INN 7702219484) was registered on 19 Feb 2003. The company's authorized capital as of July 1, 2012 was 545372000 rub. Type of ownership of LILLI FARMA, OOO - Limited liability companies. Form of ownership of LILLI FARMA, OOO - Property of foreign legal entities. Principal activities of LILLI FARMA, OOO: wholesale of pharmaceutical goods (46.46), manufacturers of drugs and pharmaceuticals and medical products (21.20), production of drugs (21.20.1). |
Economic indicators2023
Net profit (RAS) of LILLI FARMA, OOO dropped in 2023 4.29 times to 76.27 million RUB from 327.55 million RUB over the same period in 2022, the company informed. Revenue decreased in the accounting period 4.11 times to 2.07 billion RUB from 8.49 billion RUB in 2022; cost of goods sold decreased 3.90 times to 1.85 billion RUB from 7.23 billion RUB; sales loss decreased 53.78 times to 6.15 million RUB from 330.65 million RUB. 2022
Net profit (RAS) of LILLI FARMA, OOO dropped in 2022 by 37.69% to 327.55 million RUB from 525.64 million RUB over the same period in 2021, the company informed. Revenue decreased in the accounting period by 39.25% to 8.49 billion RUB from 13.97 billion RUB in 2021; cost of goods sold decreased by 42.79% to 7.23 billion RUB from 12.64 billion RUB; sales loss grew 1.92 times to 330.65 million RUB from 172.07 million RUB. 2021
Net profit (RAS) of LILLI FARMA, OOO made up 525.64 million RUB over 2021 compared to net loss of 163.73 million RUB over 2020, the company informed. Revenue increased in the accounting period by 45.48% to 13.97 billion RUB from 9.60 billion RUB over 2020; cost of goods sold grew 1.53 times to 12.64 billion RUB from 8.25 billion RUB; sales loss grew by 19.12% to 172.07 million RUB from 144.45 million RUB. 2020
Net loss (RA) of LILLI FARMA, OOO made up 163.73 million RUB over 2020 compared to net profit of 4.65 million RUB over 2019, the company informed. Revenue increased in the accounting period by 36.52% to 9.60 billion RUB from 7.03 billion RUB over 2019; cost of goods sold grew 1.58 times to 8.25 billion RUB from 5.22 billion RUB; sales loss made up 144.45 million RUB compared to sales profit of 336.67 million RUB. 2019
Net profit (RAS) of LILLI FARMA, OOO dropped in 2019 9.08 times to 4.65 million RUB from 42.22 million RUB over the same period in 2018, the company informed. Revenue increased in the accounting period by 38.54% to 7.03 billion RUB from 5.08 billion RUB over 2018; cost of goods sold grew 1.50 times to 5.22 billion RUB from 3.47 billion RUB; sales profit went up 1.57 times to 336.67 million RUB from 214.05 million RUB. 2018
Net profit (RAS) of LILLI FARMA, OOO dropped in 2018 by 41.62% to 42.22 million RUB from 72.32 million RUB over the same period in 2017, the company informed. Revenue remained in the accounting period at the same level and made up 5.08 billion RUB compared to 5.08 billion RUB 5.08 billion RUB; cost of goods sold grew by 13.00% to 3.47 billion RUB from 3.08 billion RUB; sales profit fell 2.23 times to 214.05 million RUB from 477.91 million RUB. 2017
Net profit (RAS) of LILLI FARMA, OOO dropped in 2017 by 39.62% to 72.32 million RUB from 119.77 million RUB over the same period in 2016, the company informed. Revenue decreased in the accounting period by 20.13% to 5.08 billion RUB from 6.35 billion RUB in 2016; cost of goods sold decreased by 31.55% to 3.08 billion RUB from 4.49 billion RUB; sales profit went up by 35.80% to 477.91 million RUB from 351.92 million RUB. 2016
Net profit (RAS) of LILLI FARMA, OOO made up 119.77 million RUB over 2016 compared to net loss of 37.99 million RUB over 2015, the company informed. Revenue increased in the accounting period by 6.22% to 6.35 billion RUB from 5.98 billion RUB over 2015; cost of goods sold grew by 5.29% to 4.49 billion RUB from 4.27 billion RUB; sales profit fell by 14.93% to 351.92 million RUB from 413.68 million RUB. 2014
Net profit (RAS) of LILLI FARMA, OOO grew over 2014 2.35 times to 190.18 million RUB from 80.99 million RUB over 2013, the company informed. Revenue increased in the accounting period by 23.53% to 5.71 billion RUB from 4.62 billion RUB over 2013; cost of goods sold grew by 36.94% to 4.81 billion RUB from 3.51 billion RUB; sales profit went up by 5.10% to 295.05 million RUB from 280.73 million RUB. 2013
Net profit (RAS) of LILLI FARMA, OOO dropped in 2013 2.94 times to 80.99 million RUB from 237.90 million RUB over the same period in 2012, the company informed. Revenue decreased in the accounting period by 4.26% to 4.62 billion RUB from 4.83 billion RUB in 2012; cost of goods sold decreased by 12.64% to 3.51 billion RUB from 4.02 billion RUB; sales profit fell 2.45 times to 280.73 million RUB from 689.12 million RUB. 2012
Net profit (RAS) of Lilli Farma, OOO grew over 2012 by 16.79% to 237.90 million RUB from 203.70 million RUB over 2011, the company informed. Cost of goods sold remained at the same level amounting to 4.02 billion RUB compared to 4.00 billion RUB; sales profit went up by 1.22% to 689.12 million RUB from 680.79 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|